Potent plasmodicidal activity of a heat-induced reformulation of deoxycholate-amphotericin B (Fungizone) against Plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 2, 2005, Pages 493-496

  Hatabu, Toshimitsu ^a   Takada, Tsuyoshi ^a   Taguchi, Nao ^a   Suzuki, Mamoru ^b   Sato, Kumiko ^a   Kano, Shigeyuki ^c  

^a GUNMA UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CHLOROQUINE;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENCY; DRUG SENSITIVITY; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; INCUBATION TIME; LIVER CELL; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SCHIZONT; TROPHOZOITE;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ANTIMALARIALS; CELL LINE; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; HEAT; HEMOLYSIS; HEPATOCYTES; HUMANS; PLASMODIUM FALCIPARUM;

EID: 12944305792     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.2.493-496.2005     Document Type: Article

References (21)

1. Bras, J. L., and R. Durand. 2003. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fund. Clin. Pharmacol. 17:147-153.
2. Chou, A. C., and C. D. Fitch. 1993. Control of heme polymerase by chloroquine and other quinoline derivatives. Biochem. Biophys. Res. Commun. 195:422-427.
3. Cohen, B. E. 1998. Amphotericin B toxicity and lethality: a tale of two channels. Int. J. Pharm. 162:95-106.
4. Gaboriau, F., M. Cheron, C. Petit, and J. Bolard. 1997. Heat-induced superaggregation of amphotericin B reduced its in vitro toxicity: a new way to improve its therapeutic index. Antimicrob. Agents Chemother. 41:2345-2351.
5. Gilbert, S. J., V. C. Duance, and D. J. Mason. 2004. Does protein kinase R mediate TNF-α- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism? Arthritis Res. Ther. 6:R46-R55.
6. Greeve, B., L. G. Lehman, B. Lell, D. Luckner, R. Schmidt-Ott, and P. G. Kremsner. 1999. High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. J. Infect. Dis. 179:1584-1586.
7. Hawley, S. R., P. G. Bray, M. Mungthin, J. D. Atkinson, P. M. O'Neill, and S. A. Ward. 1998. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Antimicrob. Agents Chemother. 42:682-686.
8. Ignatushchenko, M. V., R. W. Winter, and M. Riscoe. 2000. Xanthones as antimalarial agents: stage specificity. Am. J. Trop. Med. Hyg. 62:77-81.
9. Kremsner, P. G., B. Greeve, B. Lell, D. Luckner, and R. Schmidt-Ott. 2000. Malarial anemia in African children associated with high oxygen-radical production. Lancet 355:40-41.
10. Kwong, E. H., M. Ramaswamy, E. A. Bauer, S. C. Hartsel, and K. M. Wasan. 2001. Heat treatment of amphotericin B modifies its serum pharmacokinetics, tissue distribution, and renal toxicity following administration of single intravenous dose to rabbits. Antimicrob. Agents Chemother. 45:2060-2063.
11. New, R. R. C., M. L. Chance, and S. Heath. 1981. Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes. J. Antimicrob. Chemother. 8:371-381.
12. Pandey, A. V., H. Bisht, V. K. Babbarwal, J. Srivastava, K. C. Pandey, and V. S. Chauhan. 2001. Mechanism of malaria haem detoxification inhibition by chloroquine. Biochem. J. 355:333-338.
13. Petit, C., M. Cheron, V. Joly, J. M. Rodrigues, J. Bolard, and F. Gaboriau. 1998. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating. J. Antimicrob. Chemother. 42:779-785.
14. Ramos, H., E. Romero, and B. E. Cohen. 1988. The differential effect of liposomal amphotericin B on human erythrocytes and promastigotes of Leishmania sp. Acta Cient. Venez. 39:135-139.
15. Sampaio, S. A. P., R. M. Castro, N. L. Dillon, and J. E. C. Martins. 1971. Treatment of mucocutaneous leishmaniasis with amphotericin B: report of 70 cases. Int. J. Dermatol. 10:179-181.
16. Taguchi, N., T. Hatabu, H. Yamaguchi, M. Suzuki, K. Sato, and S. Kano. 2004. Plasmodium falciparum: selenium-induced cytotoxicity to Plasmodium falciparum. Exp. Parasitol. 106:50-55.
17. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
18. Venegas, B., J. González-Damián, H. Celis, and I. Ortega-Blake. 2003. Amphotericin B channels in the bacterial membrane: role of sterol and temperature. Biophys. J. 85:2323-2332.
19. Wasan, K. M., and J. S. Conklin. 1997. Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol. Clin. Infect. Dis. 24:78-80.
20. Wasan, K. M., K. Vadiei, G. Lopez-Berestein, and D. R. Luke. 1990. Pharmacokinetics, tissue distribution, and toxicity of free and liposomal amphotericin B in diabetic rats. J. Infect. Dis. 161:562-566.
21. Wongsrichanalai, C., A. L. Pickard, W. H. Wernsdorfer, and S. R. Meshnick. 2002. Epidemiology of drug-resistant malaria. Lancet Infect. Dis. 2:209-218.